|
AXCELON
About Axcelon:
Axcelon was founded in 200l in London, Ontario with a commitment to develop value added, proprietary medical devices for human health applications.
Axcelon’s activities are designed to put the company at the forefront of a new generation of medical device companies that applies nanotechnology to biodegradable polymer design and applications. It aims at developing cost-efficient tissue-engineered products that achieve their therapeutic effect through a robust design, and which can he brought to market as simple medical devices, without the need for including therapeutic molecules.
The company’s development and commercialization program is based on its proprietary technology for microbially-produced cellulose (MC) to generate new composite materials. Microbial cellulose has distinct physico-chemical characteristics that make it unique amongst biomaterials. It is a safe material of non-animal origin hat can absorb a large quantity of fluid while maintaining its shape and mechanical properties. Wound dressing applications are the initial focus of Axcelon’s efforts; however, the company’s materials technology has many other potential applications including stent coating, ophthalmology, drug delivery, regenerative medicine and other medical uses.
|
